Additional information
White Powder
331943-04-5
ACI-030902
188-190°C
C17H14F3N3O2S
381.37
Ambient
2-8°C
Anti-inflammatory
Pharmaceutical Impurity Standards
4-[3-(4-Methylphenyl)-5- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
Celecoxib Related Compound B; N-De(4-sulfonamidophenyl)-N'-(4-sulfonamidophenyl) Celecoxib; Celecoxib Isomeric Impurity





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)